25.66
0.64 (2.56%)
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Bearish |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | Avantor, Inc. | Bullish | Bullish |
Stockmoo Score
Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Mid Core |
Ownership
Name | Date | Shares Held |
---|---|---|
New Mountain Capital, L.L.C. | 30 Jun 2024 | 14,000,000 |
52 Weeks Range | ||
Price Target Range | ||
High | 31.00 (RBC Capital, 20.81%) | Buy |
31.00 (TD Cowen, 20.81%) | Buy | |
Median | 28.00 (9.12%) | |
Low | 23.00 (Citigroup, -10.37%) | Hold |
Average | 28.22 (9.98%) | |
Total | 8 Buy, 1 Hold | |
Avg. Price @ Call | 24.95 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Wells Fargo | 27 Aug 2024 | 30.00 (16.91%) | Buy | 25.61 |
Baird | 29 Jul 2024 | 27.00 (5.22%) | Buy | 26.25 |
Barclays | 29 Jul 2024 | 28.00 (9.12%) | Buy | 26.25 |
28 Jun 2024 | 25.00 (-2.57%) | Buy | 21.20 | |
Morgan Stanley | 29 Jul 2024 | 29.00 (13.02%) | Buy | 26.25 |
RBC Capital | 29 Jul 2024 | 31.00 (20.81%) | Buy | 26.25 |
15 Jul 2024 | 31.00 (20.81%) | Buy | 20.82 | |
Stifel | 29 Jul 2024 | 28.00 (9.12%) | Buy | 26.25 |
TD Cowen | 29 Jul 2024 | 31.00 (20.81%) | Buy | 26.25 |
Citigroup | 10 Jul 2024 | 23.00 (-10.37%) | Hold | 20.90 |
Evercore ISI Group | 02 Jul 2024 | 27.00 (5.22%) | Buy | 20.58 |
Show more |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |